Rocket Pharmaceuticals, Inc. · NASDAQ:RCKT

Shah Gaurav sold 2,293 Rocket Pharmaceuticals, Inc. shares (Form 4)

Traded Aug 18, 2026 · Filed Aug 20, 2026

On Aug 18, 2026, Shah Gaurav (CEO) sold 2,293 Rocket Pharmaceuticals, Inc. shares at US$3.38 for US$7,750, leaving 1,056,594 shares. Filed Aug 20, 2026 (Form 4).

Sold
2,293 shares
Price
US$3.38
Value
US$7,750
Holding after
1,056,594 shares
Trading plan
No
Role
CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 18, 2026Common StockSale2,293US$3.381,056,594Direct

Source

View original at SEC

Related